220 related articles for article (PubMed ID: 3086531)
1. Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid.
Jäger-Roman E; Deichl A; Jakob S; Hartmann AM; Koch S; Rating D; Steldinger R; Nau H; Helge H
J Pediatr; 1986 Jun; 108(6):997-1004. PubMed ID: 3086531
[TBL] [Abstract][Full Text] [Related]
2. Valproic acid and its metabolites: placental transfer, neonatal pharmacokinetics, transfer via mother's milk and clinical status in neonates of epileptic mothers.
Nau H; Rating D; Koch S; Häuser I; Helge H
J Pharmacol Exp Ther; 1981 Dec; 219(3):768-77. PubMed ID: 6795343
[TBL] [Abstract][Full Text] [Related]
3. Malformations in offspring of 305 epileptic women: a prospective study.
Battino D; Binelli S; Caccamo ML; Canevini MP; Canger R; Como ML; Croci D; De Giambattista M; Granata T; Pardi G
Acta Neurol Scand; 1992 Mar; 85(3):204-7. PubMed ID: 1575005
[TBL] [Abstract][Full Text] [Related]
4. Preliminary results on pregnancy outcomes in women using lamotrigine.
Tennis P; Eldridge RR;
Epilepsia; 2002 Oct; 43(10):1161-7. PubMed ID: 12366730
[TBL] [Abstract][Full Text] [Related]
5. Congenital abnormalities in two sibs exposed to valproic acid in utero.
Chitayat D; Farrell K; Anderson L; Hall JG
Am J Med Genet; 1988 Oct; 31(2):369-73. PubMed ID: 3148279
[TBL] [Abstract][Full Text] [Related]
6. Three cases of delivery under sodium valproate--placental transfer, milk transfer and probable teratogenicity of sodium valproate.
Tsuru N; Maeda T; Tsuruoka M
Jpn J Psychiatry Neurol; 1988 Mar; 42(1):89-96. PubMed ID: 3135429
[TBL] [Abstract][Full Text] [Related]
7. Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based register study.
Wide K; Winbladh B; Källén B
Acta Paediatr; 2004 Feb; 93(2):174-6. PubMed ID: 15046269
[TBL] [Abstract][Full Text] [Related]
8. The teratogenicity of anticonvulsant drugs.
Holmes LB; Harvey EA; Coull BA; Huntington KB; Khoshbin S; Hayes AM; Ryan LM
N Engl J Med; 2001 Apr; 344(15):1132-8. PubMed ID: 11297704
[TBL] [Abstract][Full Text] [Related]
9. Valproic acid monotherapy in pregnancy and major congenital malformations.
Jentink J; Loane MA; Dolk H; Barisic I; Garne E; Morris JK; de Jong-van den Berg LT;
N Engl J Med; 2010 Jun; 362(23):2185-93. PubMed ID: 20558369
[TBL] [Abstract][Full Text] [Related]
10. Increased rate of major malformations in offspring exposed to valproate during pregnancy.
Wyszynski DF; Nambisan M; Surve T; Alsdorf RM; Smith CR; Holmes LB;
Neurology; 2005 Mar; 64(6):961-5. PubMed ID: 15781808
[TBL] [Abstract][Full Text] [Related]
11. Fetal Valproate Syndrome.
Mutlu-Albayrak H; Bulut C; Çaksen H
Pediatr Neonatol; 2017 Apr; 58(2):158-164. PubMed ID: 27422007
[TBL] [Abstract][Full Text] [Related]
12. Dose-dependent teratogenicity of valproate in mono- and polytherapy: an observational study.
Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F;
Neurology; 2015 Sep; 85(10):866-72. PubMed ID: 26085607
[TBL] [Abstract][Full Text] [Related]
13. Valproic acid concentrations in nursing mothers, mature milk, and breastfed infants in monotherapy and combination therapy.
Kacirova I; Grundmann M; Brozmanova H
Epilepsy Behav; 2019 Jun; 95():112-116. PubMed ID: 31035102
[TBL] [Abstract][Full Text] [Related]
14. Verification of the fetal valproate syndrome phenotype.
Ardinger HH; Atkin JF; Blackston RD; Elsas LJ; Clarren SK; Livingstone S; Flannery DB; Pellock JM; Harrod MJ; Lammer EJ
Am J Med Genet; 1988 Jan; 29(1):171-85. PubMed ID: 3125743
[TBL] [Abstract][Full Text] [Related]
15. Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy.
Samrén EB; van Duijn CM; Koch S; Hiilesmaa VK; Klepel H; Bardy AH; Mannagetta GB; Deichl AW; Gaily E; Granström ML; Meinardi H; Grobbee DE; Hofman A; Janz D; Lindhout D
Epilepsia; 1997 Sep; 38(9):981-90. PubMed ID: 9579936
[TBL] [Abstract][Full Text] [Related]
16. Benzodiazepine amplification of valproate teratogenic effects in children of mothers with absence epilepsy.
Laegreid L; Kyllerman M; Hedner T; Hagberg B; Viggedahl G
Neuropediatrics; 1993 Apr; 24(2):88-92. PubMed ID: 7687042
[TBL] [Abstract][Full Text] [Related]
17. Malformations, withdrawal manifestations, and hypoglycaemia after exposure to valproate in utero.
Thisted E; Ebbesen F
Arch Dis Child; 1993 Sep; 69(3 Spec No):288-91. PubMed ID: 8215567
[TBL] [Abstract][Full Text] [Related]
18. Antiepileptics and the development of congenital anomalies.
Yerby MS; Leavitt A; Erickson DM; McCormick KB; Loewenson RB; Sells CJ; Benedetti TJ
Neurology; 1992 Apr; 42(4 Suppl 5):132-40. PubMed ID: 1574169
[TBL] [Abstract][Full Text] [Related]
19. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry.
Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Sabers A; Perucca E; Vajda F;
Lancet Neurol; 2011 Jul; 10(7):609-17. PubMed ID: 21652013
[TBL] [Abstract][Full Text] [Related]
20. The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort.
Omtzigt JG; Los FJ; Grobbee DE; Pijpers L; Jahoda MG; Brandenburg H; Stewart PA; Gaillard HL; Sachs ES; Wladimiroff JW
Neurology; 1992 Apr; 42(4 Suppl 5):119-25. PubMed ID: 1574165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
